We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Guardant Health Inc | NASDAQ:GH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.28 | -1.47% | 18.82 | 18.83 | 19.49 | 19.255 | 18.78 | 19.19 | 1,400,388 | 22:47:40 |
1. Name and Address of Reporting Person * Eltoukhy Helmy | 2. Issuer Name and Ticker or Trading Symbol Guardant Health, Inc. [ GH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Executive Officer |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
COMMON STOCK | 4/20/2021 | S | 1711 (1) | D | $148.1017 (2) | 1906556 | D | |||
COMMON STOCK | 4/20/2021 | S | 699 (1) | D | $149.4701 (3) | 1905857 | D | |||
COMMON STOCK | 4/20/2021 | S | 3752 (1) | D | $150.2655 (4) | 1902105 | D | |||
COMMON STOCK | 4/20/2021 | S | 7677 (1) | D | $151.3027 (5) | 1894428 | D | |||
COMMON STOCK | 4/20/2021 | S | 2168 (1) | D | $152.1086 (6) | 1892260 | D | |||
COMMON STOCK | 4/21/2021 | S | 3500 (1) | D | $148.3521 (7) | 1888760 | D | |||
COMMON STOCK | 4/21/2021 | S | 3900 (1) | D | $149.1127 (8) | 1884860 | D | |||
COMMON STOCK | 4/21/2021 | S | 5556 (1) | D | $150.9257 (9) | 1879304 | D | |||
COMMON STOCK | 4/21/2021 | S | 18150 (1) | D | $151.7956 (10) | 1861154 | D | |||
COMMON STOCK | 4/21/2021 | S | 23879 (1) | D | $152.7646 (11) | 1837275 | D | |||
COMMON STOCK | 4/21/2021 | S | 1373 (1) | D | $153.255 (12) | 1835902 | D | |||
COMMON STOCK | 365775 | I | Shares held by Eltoukhy Investments, L.P. |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Eltoukhy Helmy 505 PENOBSCOT DRIVE REDWOOD CITY, CA 94063 | X | Chief Executive Officer |
Signatures | ||
/s/ John Saia, as attorney-in-fact for Helmy Eltoukhy | 4/22/2021 | |
**Signature of Reporting Person | Date |
1 Year Guardant Health Chart |
1 Month Guardant Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions